Among these, sodium-dependent glucose transporters 2 (SGLT2) in kidney has been emerged as an attractive target because it is closely involved in T2DM with a distinct mechanism that reduce blood glucose levels independently of insulin secretion. Here, SLC5A2 is linked to type 2 diabetes mellitus.